SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 121 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $242,000 | -34.2% | 11,468 | -7.2% | 0.03% | -34.7% |
Q2 2014 | $368,000 | +15.4% | 12,363 | -6.8% | 0.05% | +14.0% |
Q1 2014 | $319,000 | +17.7% | 13,263 | -0.4% | 0.04% | +16.2% |
Q4 2013 | $271,000 | -72.3% | 13,318 | -35.8% | 0.04% | -74.8% |
Q3 2013 | $980,000 | +219.2% | 20,740 | +156.7% | 0.15% | +212.8% |
Q2 2013 | $307,000 | – | 8,078 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |